AssetMark Inc’s Immunogen Inc IMGN Stock Holding History

AssetMark Inc’s Portfolio IMGN Stock Details IMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-3,880	Closed	-$115K	–	2165
2023 Q4	$115K	Buy	3,880 +1,210	+45%	+$24.1K	﹤0.01%	1016
2023 Q3	$42.4K	Buy	2,670 +96	+4%	+$1.6K	﹤0.01%	1131
2023 Q2	$48.6K	Buy	+2,574	New	+$30.4K	﹤0.01%	1084
2019 Q4	–	Sell	-169	Closed	–	–	1498
2019 Q3	$0	Hold	169	–	–	﹤0.01%	1459
2019 Q2	$0	Hold	169	–	–	﹤0.01%	1455
2019 Q1	$0	Hold	169	–	–	﹤0.01%	1542
2018 Q4	$1K	Hold	169	–	–	﹤0.01%	1378
2018 Q3	$2K	Hold	169	–	–	﹤0.01%	1294
2018 Q2	$2K	Hold	169	–	–	﹤0.01%	1291
2018 Q1	$2K	Hold	169	–	–	﹤0.01%	1292
2017 Q4	$1K	Buy	+169	New	+$1.04K	﹤0.01%	1759

Other funds holding IMGN

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Mather Group Chicago, Illinois $10B AUM 15.14% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

AssetMark Inc's IMGN Position: Q1 2024 in Review

AssetMark Inc sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 3,880 shares — an estimated $115K sold.

AssetMark Inc first reported a position in IMGN in Q4 2017 and held it in 11 quarters. The position peaked at $115K in Q4 2023. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.

AssetMark Inc reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
AssetMark Inc sold 3,880 Immunogen Inc shares in Q1 2024, an estimated $115K.
AssetMark Inc first reported a position in Immunogen Inc in Q4 2017 and held it in 11 quarters.
AssetMark Inc's Immunogen Inc position peaked at $115K in Q4 2023.
3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.

Based on AssetMark Inc's 13F filing for Q1 2024, filed 7 May 2024.